November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering Yong-In KimCEO at NEORTESBIOSpeaker
Profile
Dr. Yong-In Kim is the Founder and CEO of NEORETESBIO Inc., with over 25 years of experience in biologics R&D across inflammation, autoimmune, and ophthalmic diseases. He contributed to the development of HUMIRA® and other antibody programs at Abbott (USA), led ophthalmology biologics programs at Novartis (USA), and established the antibody platform and vascular biology programs at Samsung SAIT. Dr. Kim earned his Ph.D. in Biochemistry from Texas A&M and completed his postdoctoral training at MIT.
Agenda Sessions
Ophthalmology: NEORTESBIO
, 13:30View Session